Antigen Presentation by Dendritic Cells In Vivo
暂无分享,去创建一个
N. Glaichenhaus | S. Hugues | E. Mougneau | Stéphanie Hugues | Nicolas Glaichenhaus | Evelyne Mougneau
[1] F. Huang,et al. A Discrete Subpopulation of Dendritic Cells Transports Apoptotic Intestinal Epithelial Cells to T Cell Areas of Mesenteric Lymph Nodes , 2000, The Journal of experimental medicine.
[2] J. Miller,et al. Constitutive class I-restricted exogenous presentation of self antigens in vivo , 1996, The Journal of experimental medicine.
[3] R. Steinman,et al. High Levels of a Major Histocompatibility Complex II–Self Peptide Complex on Dendritic Cells from the T Cell Areas of Lymph Nodes , 1997, The Journal of experimental medicine.
[4] R. Flavell,et al. Local expression of TNFalpha in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens. , 1998, Immunity.
[5] Javier Hernández,et al. Phenotypic and Functional Analysis of Cd8+ T Cells Undergoing Peripheral Deletion in Response to Cross-Presentation of Self-Antigen , 2001, The Journal of experimental medicine.
[6] Michel C. Nussenzweig,et al. Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[7] A. Rudensky,et al. Monoclonal antibody detection of a major self peptide. MHC class II complex. , 1992, Journal of immunology.
[8] R. Germain,et al. Dynamic Imaging of T Cell-Dendritic Cell Interactions in Lymph Nodes , 2002, Science.
[9] David W. Marsh,et al. CD4+ T Cell Tolerance to Parenchymal Self-Antigens Requires Presentation by Bone Marrow–derived Antigen-presenting Cells , 1998, The Journal of experimental medicine.
[10] W. Heath,et al. Cross-presentation in viral immunity and self-tolerance , 2001, Nature Reviews Immunology.
[11] R. Steinman. Inaugural Article : avoiding horror autotoxicus. The importance of dendritic cells in peripheral T cell tolerance , 2002 .
[12] Ethan M. Shevach,et al. Constitutive Presentation of a Natural Tissue Autoantigen Exclusively by Dendritic Cells in the Draining Lymph Node , 2002, The Journal of experimental medicine.
[13] Polly Matzinger,et al. Does T-cell tolerance require a dedicated antigen-presenting cell? , 1989, Nature.
[14] N. Glaichenhaus,et al. Tolerance to islet antigens and prevention from diabetes induced by limited apoptosis of pancreatic beta cells. , 2002, Immunity.
[15] C. Kurts,et al. Cutting Edge: Dendritic Cells Are Sufficient to Cross-Present Self-Antigens to CD8 T Cells In Vivo1 , 2001, The Journal of Immunology.
[16] Simon C Watkins,et al. Dendritic Cells Acquire Antigens from Live Cells for Cross-Presentation to CTL1 , 2001, The Journal of Immunology.
[17] J. Miller,et al. CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[18] M. Bevan,et al. Cd8+ but Not Cd8− Dendritic Cells Cross-Prime Cytotoxic T Cells in Vivo , 2000, The Journal of experimental medicine.
[19] C. Kurts,et al. Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo. , 2001, Journal of immunology.
[20] E. Kedar,et al. Lysis of murine macrophages infected with intracellular pathogens by interleukin 2-activated killer (LAK) cells in vitro. , 1988, Cellular immunology.
[21] R. Steinman,et al. Migration and maturation of Langerhans cells in skin transplants and explants , 1990, The Journal of experimental medicine.
[22] R. Germain,et al. Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[23] D. Green,et al. Uptake of Apoptotic Antigen-Coupled Cells by Lymphoid Dendritic Cells and Cross-Priming of CD8+ T Cells Produce Active Immune Unresponsiveness1 , 2002, The Journal of Immunology.
[24] Steffen Jung,et al. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. , 2002, Immunity.
[25] R. Steinman,et al. Immune Tolerance After Delivery of Dying Cells to Dendritic Cells In Situ , 2002, The Journal of experimental medicine.
[26] Mark J. Miller,et al. Two-Photon Imaging of Lymphocyte Motility and Antigen Response in Intact Lymph Node , 2002, Science.
[27] E. Unanue,et al. Characterization and quantitation of peptide-MHC complexes produced from hen egg lysozyme using a monoclonal antibody. , 1997, Immunity.
[28] M. Winslow,et al. Major Histocompatibility Complex Class II Presentation of Cell-associated Antigen Is Mediated by CD8α+ Dendritic Cells In Vivo , 2002, The Journal of experimental medicine.
[29] C. Kurts,et al. Brief Definitive Report Major Histocompatibility Complex Class I–restricted Cross-presentation Is Biased towards High Dose Antigens and Those Released during Cellular Destruction , 2022 .
[30] M. Lebwohl,et al. Blockade of T Lymphocyte Costimulation with Cytotoxic T Lymphocyte–Associated Antigen 4–Immunoglobulin (Ctla4ig) Reverses the Cellular Pathology of Psoriatic Plaques, Including the Activation of Keratinocytes, Dendritic Cells, and Endothelial Cells , 2000, The Journal of experimental medicine.
[31] R. Steinman,et al. The CD8+ Dendritic Cell Subset Selectively Endocytoses Dying Cells in Culture and In Vivo , 2002, The Journal of experimental medicine.
[32] Scott N. Mueller,et al. The CD8α+ Dendritic Cell Is Responsible for Inducing Peripheral Self-Tolerance to Tissue-associated Antigens , 2002, The Journal of experimental medicine.
[33] C. Kurts,et al. Class I–restricted Cross-Presentation of Exogenous Self-Antigens Leads to Deletion of Autoreactive CD8+ T Cells , 1997, The Journal of experimental medicine.
[34] Michel C. Nussenzweig,et al. Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo , 2001, The Journal of experimental medicine.
[35] I. Lieberam,et al. Peripheral tolerance of CD4 T cells following local activation in adolescent mice , 1996, European journal of immunology.
[36] J. Yewdell,et al. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. , 1997, Immunity.
[37] Yong‐jun Liu,et al. Mouse and human dendritic cell subtypes , 2002, Nature Reviews Immunology.
[38] E. Unanue,et al. Quantitation of Lysozyme Peptides Bound to Class II MHC Molecules Indicates Very Large Differences in Levels of Presentation1 , 2001, The Journal of Immunology.